Quick Heal Tech

The company missed its target of 40% cloud-based revenue for the enterprise segment by Q1 FY2026. As of H1 FY2026, the cloud mix stands at 37%, although it has improved from 31% in FY25. (2 missed, 1 met, 1 in progress across 4 tracked commitments)

Despite the commitment to improve margins, EBITDA margins for 9M FY26 fell to 0.0% compared to 0.9% in 9M FY25, and Gross Margins slightly declined from 97.1% to 97.0%. (2 missed across 2 tracked commitments)

Focus on maintaining market share in the Antivirus (AV) segment while positioning AntiFraud.AI to tackle financial frauds.

Fulfillment of a large INR 64 Cr order for integrated cybersecurity solutions over a 5-year period. — target: INR 64 Cr (+1 more commitment)

The company is using a freemium model for the new Anti Fraud.AI product to accelerate consumer adoption.

The Enterprise segment has reached revenue parity with the Consumer segment, now contributing 50% of total revenue. While gross revenue for the quarter (₹31.7 Cr) showed a slight YoY decline of 2.3%, the segment's share of the total business has expanded significantly from 40% in FY25. (4 expanding)

The enterprise segment faced headwinds with flattish year-on-year results due to deferred deal closures, though the order book remains healthy at Rs. 24 crores. (1 stable, 4 expanding)

The company is evolving its technology moat by integrating AI-driven threat detection (GoDeep.AI) and launching an AI-powered assistant (SIA) for enterprise security. (3 expanding, 1 shifted)

The company has launched a new growth lever focused on Data Privacy, securing its first order for the Seqrite Data Privacy product, likely driven by upcoming Indian regulations. (2 new, 1 expanding, 1 shifted)

While India remains the primary market, the company is seeing explosive growth in international revenue, which doubled year-over-year, indicating a strategic push to diversify beyond domestic borders. (1 expanding, 1 shifted)

Profitability has reversed into negative territory this quarter due to a significant revenue dip in the consumer segment and deferred enterprise deals, while operating costs remained fixed at Rs. 66 crores. (1 reversing, 2 accelerating across 3 signals)

The enterprise order book has seen an explosive increase in the most recent quarter, jumping from a negligible base to over 7 Crore. (2 accelerating, 2 reversing, 1 new trend across 5 signals)

The company has identified a massive expansion in its addressable market to INR 4,000 crores over the next 2-3 years, specifically targeting the 'Make in India' preference in government and mid-market segments. (2 new trend across 2 signals)

Deferred revenue, representing future income from services already sold, is showing steady growth, indicating a healthy pipeline of upcoming revenue recognition. (2 steady, 1 new trend across 3 signals)

Profitability has reversed into negative territory as the company increases spending on R&D and Sales/Marketing to fuel its enterprise transition. (2 reversing across 2 signals)

The company remains loss-making with a PAT of negative Rs. 5.5 crore this quarter. While revenue fell, operating costs remained flat at Rs. 66 crores, leading to continued bottom-line pressure. (1 stable, 1 intensifying, 2 easing, 1 high-severity)

Management took the drastic step of stopping sales (curtailing invoicing) to specific partners due to overdue receivables. While they saw a positive trend in July, the proactive restriction of sales to manage credit risk confirms the severity of the collection issue. (5 intensifying, 2 high-severity)

The risk is easing as the company successfully shifts its enterprise mix. Cloud revenue now accounts for 40% of the enterprise business, up from 31% in FY25 and 23% in FY24. (3 easing)

Enterprise revenue was 'flattish' year-on-year due to deal deferrals. While the order book is Rs. 24 crores, the segment is not yet growing fast enough to compensate for the consumer decline, and the CEO is departing during this critical pivot. (1 intensifying, 4 easing)

The risk is intensifying as the government has yet to issue final implementation guidelines, causing a delay in the expected 'explosion' of demand for compliance products. However, the company won one large BFSI deal, showing some early traction despite the delay. (1 intensifying, 1 emerging, 3 easing)